November 12, 2012 15:08
FAS green-lights AFK Sistema bid to buy 100% of VeroPharm, but with terms (Part 2)
MOSCOW. Nov 12 (Interfax) - Russia's Federal Antimonopoly Service (FAS) has approved AFK Sistema's (RTS: AFKS) request for permission to buy 100% of the stock in pharmaceuticals company OJSC VeroPharm (RTS: VRPH), but has attached some terms, a FAS statement says.
The FAS established that VeroPharm has a dominating position on the market for medicines with MNN Gemifloksatsin, and its subsidiary LLC LENS-Pharm with MNN Poliadenilovaya Kislota + Poliuridilovaya Kislota.
The FAS takes the view that the conduct of this deal could lead to a limiting of access to the market for the sale of these medical preparations by independent counteragent VeroPharm and LENS-Pharm. In light of this, the FAS requires of Sistema and VeroPharm to ensure the fulfillment of all contracts for the delivery of all medicines existing on the date the deal is completed.
Before the deal is done, Sistema is to post on its official website the document regulating its commercial policy as regards VeroPharm medical preparations, and announce changes to commercial policy in letter form to the FAS within thirty days.
The parties are not to, from the date the deal is completed, effect any unfounded economic or technological reduction or halt of the production and supply of goods that are still in demand. They are also to announce to the FAS either of such circumstances in letter form within thirty days.
AFK Sistema and VeroPharm are to annually inform the FAS in letter form that they are meeting these conditions.
The parties to the deal are to announce its completion to the anti-monopoly agency within twenty days from the day the deal is wrapped up.
According to DSM Group data, VeroPharm is third in a rating of the largest Russian pharmaceutical companies. Company product is provided by three plants: in Belgorod, Voronezh, and Pokrov. VeroPharm specializes in the production of Rx medical goods, which account for about 70% of its sales revenues.
Pharmacy Chain 36.6 (RTS: APTK) owns 51.8% of the company.
(Our editorial staff can be reached at firstname.lastname@example.org)
August 24, 2016
Moscow interbank actual rate
Israeli embassy doesn't confirm reports on possible meeting between Abbas, Netanyahu in Moscow
Tajik parliamentarians approve law on amnesty
Kazakh, Polish development banks agree 300 mln euro in projects
Business confidence falls in Russian extractive industry in Aug for first time in 7M - Rosstat
Polish president promises support for Kyiv's Euro-Atlantic aspirations (Part 2)
Udmurtia lawmaker beats oil majors to Yakutia license
Russian consumer price growth resumes with 0.1% inflation for week - Rosstat
MICEX and RTS Indexes at 16:00 MSK
RUSSIA HAS INFLATION OF 0.1% FOR WEEK, FIRST WEEKLY PRICE GROWTH IN FOUR WEEKS - ROSSTAT
Kyiv ready to conduct dialogue on controversial historical issues with Warsaw - Poroshenko
State contract for construction of six subs carrying cruise missiles Kalibr for Pacific Fleet will be signed at ARMY-2016 forum - source
Moscow court sentences nationalist Potkin to 7.5 years in prison, heavy fine